Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer, Published online: 13 December 2018; doi:10.1038/s41388-018-0624-2Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer (Source: Oncogene)
from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader https://ift.tt/2RZm7X4
via IFTTT
Πέμπτη 13 Δεκεμβρίου 2018
Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Purpose To test the effects of 4 weeks of unilateral low-load resistance training (LLRT), with and without blood flow restricti...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2juls25 via IFTTT
-
Swedish medical imaging software developer SyntheticMR has received the CE... Read more on AuntMinnieEurope.com Related Reading: Siemen...
-
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor British Journal of Canc...
-
ACS Nano DOI: 10.1021/acsnano.6b06114 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2kOsUGq via...
-
Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intract...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qoeMDm via IFTTT
-
Relativistic hydrodynamics has been quite successful in explaining the collective behaviour of the QCD matter produced in high energy heavy-...
-
GE Healthcare has introduced Logiq S8 XDclear 2.0, an ultrasound system that... Read more on AuntMinnieEurope.com Related Reading: GE r...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου